Similar Search Results

On the Legitimacy of Coercion for the Financing of Public Goods

Bierbrauer, Felix - CESifo - 2009

The literature on public goods has shown that efficient outcomes are impossible if participation constraints have to be respected. This paper addresses the question whether they should be imposed. It asks under what conditions efficiency considerations justify that individuals are forced to pay...

Persistent link: https://www.econbiz.de/10004979415

Incentives to (Irreversible) Investments Under Different Regulatory Regimes

Scarpa, Carlo; Panteghini, Paolo - CESifo - 2001

This paper addresses the issue of how regulatory constraints affect firm's investment choices when the firm has the option to delay investment. The RPI-x rule is compared to a profit sharing rule, which increases the x factor in case profits go beyond a given level. It is shown that these rules...

Persistent link: https://www.econbiz.de/10005765883

Competition and Quality in Regulated Markets with Sluggish Demand

Brekke, Kurt R.; Cellini, Roberto; Siciliani, Luigi; … - CESifo - 2010

We investigate the effect of competition on quality in regulated markets (e.g., health care, higher education, public utilities), using a Hotelling framework, in the presence of sluggish demand. We take a differential-game approach, and derive the open-loop solution (providers choose the optimal...

Persistent link: https://www.econbiz.de/10008572490

Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?

Brekke, Kurt R.; Grasdal, Astrid L.; Holmås, Tor Helge - CESifo - 2007

-patent pharmaceuticals, replacing the existing price cap (PC) regulation. We estimate the effect of the reform using a product level panel … dataset, covering the drugs exposed to RP and a large number of drugs still under PC regulation in the time before and after … regulation in lowering drug prices, while the cross-price effect raises a concern about patent protection. …

Persistent link: https://www.econbiz.de/10005406112

Disposal of Petroleum Installations - Major Policy Issues

Osmundsen, Petter; Tveterås, Ragnar - CESifo - 2000

Following the Brent Spar controversy, the OSPAR countries reached a unanimous agreement in 1998 for the future rules for disposal of petroleum installations. The vast majority of existing offshore installations will be re-used or returned to shore for recycling or disposal. For installations...

Persistent link: https://www.econbiz.de/10005406247

Reference Pricing of Pharmaceuticals

Brekke, Kurt R.; Königbauer, Ingrid; Straume, Odd Rune - CESifo - 2006

We consider a therapeutic market with potentially three pharmaceutical firms. Two of the firms offer horizontally differentiated brand-name drugs. One of the brand-name drugs is a new treatment under patent protection that will be introduced if the profits are sufficient to cover the entry...

Persistent link: https://www.econbiz.de/10005406396

Net Neutrality and Investment Incentives

Choi, Jay Pil; Kim, Byung-Cheol - CESifo - 2008

This paper analyzes the effects of net neutrality regulation on investment incentives for Internet service providers …

Persistent link: https://www.econbiz.de/10005196250

Market Entry Regulation and International Competition

Upmann, Thorsten; Stähler, Frank - CESifo - 2003

As a part of their industry or competition policies governments decide whether to allow for free market entry of firms or to regulate market access. We analyze a model where governments (ab)use these policy decisions for strategic reasons in an international setting. Multiple equilibria of this...

Persistent link: https://www.econbiz.de/10005196323

Regulatory Risk under Optimal Incentive Regulation

Strausz, Roland - CESifo - 2009

The paper provides a tractable, analytical framework to study regulatory risk. Regulatory risk is captured by uncertainty about the policy variables in the regulator’s objective function: weights attached to profits and costs of public funds. Results are as follows: 1) The regulator’s...

Persistent link: https://www.econbiz.de/10005051541

Reference Pricing, Competition, and Pharmaceutical Expenditures: Theory and Evidence from a Natural Experiment

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - CESifo - 2010

We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using … a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub …-sample of off-patent products. First, we construct a vertical differentiation model to analyze the impact of regulation on …

Persistent link: https://www.econbiz.de/10008799730